Proteomics of acute myeloid leukemia: [Elektronische Ressource] : cytogenetic risk groups differ specifically in their proteome, interactome and posttranslational protein modifications / vorgelegt von Mumtaz Yaseen Balkhi

Aus der Medizinischen Klinik und Poliklinik III-Großhadern-der Ludwig-Maximilians-Universitäts München, Director: Prof. Dr. Wolfgang Hiddeman Proteomics of Acute Myeloid Leukemia: Cytogenetic Risk Groups Differ Specifically in their Proteome, Interactome and Posttranslational Protein Modifications Dissertation zum Erwerb des Doktorgrades der Humanbiologie an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München Vorgelegt von Mumtaz Yaseen Balkhi aus Soura-Srinagar, India 2007 From the Department of Internal Medicine III, Ludwig-Maximilians-University, Munich Director: Prof. Dr. Wolfgang Hiddeman Proteomics of Acute Myeloid Leukemia: Cytogenetic Risk Groups Differ Specifically in their Proteome, Interactome and Posttranslational Protein Modifications Thesis Submitted for a Doctoral degree in Human Biology at the faculty of Medicine Ludwig-Maximilians-University, Munich Submitted by Mumtaz Yaseen Balkhi From Soura-Srinagar, India 2007 Mit Genehmigung der Medizinischen Fakultät der Universität München Berichterstatter: Prof. Dr.